Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Concord Biotech Limited
CONCORDBIO | NSE
1,092.30
INR-8.70
-0.79%
CONCORDBIO | NSE
Loading StockChartView...
About Concord Biotech Limited
Sector
Healthcare
Industry
Biotechnology
Earnings date
31/03/2024
As of date
20/03/2026
Close
1,092.30
Open
1,104.80
High
1,125.80
Low
1,078.90
View Less
CONCORDBIO | NSE
Risk
58.2
Sharpe
-0.96
Luna's Score
54/100
Recommendation
Hold
Luna says (CONCORDBIO | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
32.2%1 month
58.2%3 months
51.6%6 months
41.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
67.34
Fwd. PE
-
Price to book
13.69
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
43.02
Ent. to rev.
20.13
PEG
-
Other Fundamentals
EBITDA
4.47B
MarketCap
115.34B
MarketCap(USD)
1.23B
Div. yield
0.44
Op. margin
31.56
Erngs. growth
9.40
Rev. growth
10.80
Ret. on equity
21.88
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
148.00
Range1M
222.70
Range3M
386.40
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.20
Price X volume
189.83M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 43.02 | 54.00 | Cheaper |
| Ent. to Revenue | 20.13 | 7.68 | Expensive |
| PE Ratio | 67.34 | 53.67 | Expensive |
| Price to Book | 13.69 | 6.76 | Expensive |
| Dividend Yield | 0.44 | 0.26 | Leader |
| Std. Deviation (3M) | 51.55 | 50.01 | Par |
| Debt to Equity | 0.01 | -0.16 | Expensive |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 115.34B | 129.43B | Par |
